Forum Replies Created
-
AuthorPosts
-
3 March 2017 at 5:32 am in reply to: Please check for medication interactions (+ website link) #25467
Tyroxine does not interact with Sof/Led or Sof/Vel
For daclatasvir it says:
Coadministration has not been studied and thyroid metabolism is complicated. The major pathway is sequential deiodination (but there are few published data on the enzymes involved) and conjugation with glucuronides and sulphates also occurs. A few individual case reports indicate some potential CYP involvement but this is unlikely to be clinically significant. Data suggest that endogenous T3 and T4 may be transported by OATP1B1 which is inhibited by daclatasvir but it is not clear if this is likely to be clinically significant. Monitor thyroid function tests.
Which in English is “Don’t worry about this, just test your thyroid levels (TSH) during treatment, say every 4 weeks”
YMMV
When I found this wonderful place I wanted to paint it on a railroad car
Believe it or not, on the rainy Sunday afternoon when I was designing the logo one of the thoughts was to make something you could actually paint on the side of a building/railroad car using a spray can and paint brush.
YMMV
3 March 2017 at 5:11 am in reply to: Patients in USA need to act now to cure via Generic Medication #25464The idea that this can go on forever, and that there is no incentive for Big Pharma to move to shut it down is optimistic.
It has been allowed to continue to date because we are not a big enough thorn to worry about, however….
At some point, as happened with HIV generics, there will be a massive shit fight.
On that note Dragisa Zekic, a Serbian Hep C activist, has been arrested by Serbian police who raided the family home taking generic Hepatitis C medicines, Dragisa and his computer. It’s probably easier to orchestrate in the old Eastern bloc, but we know from history that people will go to extraordinary lengths to protect profits.
As Greedfighter has said often – if you’re sitting on the fence there will never be a better time to jump than now. Tomorrow remains anyone’s guess, but history suggests troubled waters in the future.
YMMV
It’s worth remembering that the Hepatitis Trust in the UK does have a generics page (and indeed was amongst the first to have one)
http://www.hepctrust.org.uk/information/treatment/buying-hepatitis-c-drugs-online
And their CEO Charles Gore treated with PEG/Riba back in the bad old days:
http://www.worldhepatitisalliance.org/story/2015-04/charles-gore
So although taking money from pharma introduces the question of what impact it may have had, the trust seems to have been navigating an honourable path.
YMMV
Hello G1,
You’re welcome to be here.
Checking your LFTs at week 4 will provide reassurance that things are working, but won’t actually change the outcome of treatment so can be skipped if the money needs to go elsewhere. You should be able to feel things working in terms of feeling better.
The “big test” is the one for viral load 12 weeks after you finish.
YMMV
Hi JT,
I’m glad you posted. Although 1,800,000 to 400 is a good drop it’s not where we like to see things at this point.
We should have a chat about it. That can be online here or offline.
The upshot is that in a VA study of 4200 veterans taking Harvoni the overall SVR rate was 91.3% but for patients still detectable at 28 days it was more like 82%.
So to improve those odds for you we should be making a bit of a change to your treatment by either adding another drug or extending it with something more potent.
Your odds of SVR are still good if we do nothing but this is an early warning your personal HCV is relatively resistant and could do with being hit with a bigger hammer.
YMMV
Welcome,
Gaj made some instructions for how to add your signature here: https://fixhepc.com/forum/technical-support/977-how-to-add-signature-details-to-your-profile.html
Essentially click on “You” to the left of your post to get to your profile. Click on Edit >> at the top middle right, then “Profile Information” tab and scroll down to your signature. Add and save and it’s done.
YMMV
There are two baseline factors.
- Water solubility.
- Lipid membrane permeability.
We need a drug to be water soluble to dissolve in the stomach.
BUT
We also need it to be fat (lipid) soluble to “float” through the gut lining and into the blood (unless there is a transporter it can hijack).
You may notice that we want both water and fat soluble.
Things that are say like salt or sugar dissolve easily in water, but ever tried to dissolve them in oil?
Similarly things like chewing gum won’t dissolve in water, but will dissolve in oil (fast into orange oil gum remover for example).
Given these two almost opposite requirements only about 30% of medications have this physical characteristic. Basically they have a polar (water loving) and non polar (lipid loving) part. Technically hydrophilic (water loving) and hydrophobic (water hating, oil loving) parts.
In day to day life dish washing detergent and alcohol are two common things that have this dual nature.
BCS class I chemicals are water soluble and permeable (detergant, alcohol)
BCS class II chemicals are relatively insoluble but permeable (oily)
BSC class III chemicals are soluble but relatively impermeable (salty)
And BCS class IV chemicals a insoluble and impermeable (ie like sand or rock)Velpatasvir is BCS class IV.
YMMV
This is a bump for this post.
Just a quick reminder to people that there is more to medication that just the purity of the API. For most medications formulation plays an important role in making them “bioavailable”. Bioavailable means that they can get into your body to do their work. If they don’t get in you might as well be swallowing sand.
With good factory options available I suggest using those, but if you insist on using API please choose Sofosbuvir and Daclatasvir ONLY.
Ledipasvir is far less forgiving and Velpatasvir will simply not be absorbed (it is BCS class IV – insoluble and impermeable). Voxilaprevir is likely to be just as problematic as Velpatasvir so while you might be able to source it, you would do far better to wait for a generic factory formulation.
YMMV
DHL > FedEx > EMS
They all usually deliver with various degrees of delay and grief.
YMMV
It is possible to treat people <18 with DAAs but as they are only approved for people over 18 there is an extensive discussion required.
It has been done before. Here is the journey of a 15 yo boy who was treated.
http://fixhepc.com/forum/patient-stories/311-young-j-the-dragon-slayer.html
YMMV
The need for extended treatment is to increase the success rate.
The cirrhosis will continue to get worse if the disease is not cured.
YMMV
18 February 2017 at 7:07 am in reply to: Abbvie ABT-493/ABT-530 gets FDA breakthrough therapy designation #25340I’m aware of at least one of the Bangladesh Pharma companies looking at it now, so probably yes. After Sof/Vel/Vox the next logical candidate for a generic is ABT-493/ABT-530
YMMV
-
AuthorPosts